CalciMedica, Inc. Basic Shares Outstanding (Weighted Average)
CalciMedica, Inc. (CALC) reported Basic Shares Outstanding (Weighted Average) of 17.10 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-11
- CalciMedica, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 17.10M shares, a 14.04% increase year-over-year.
- CalciMedica, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 15.82M shares, a 12.04% increase year-over-year.
- CalciMedica, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 15.84M shares, a 22.23% increase year-over-year.
- CalciMedica, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 15.08M shares, a 35.40% increase year-over-year.
- CalciMedica, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 15.01M shares, a 33.48% increase from fiscal 2024.
- CalciMedica, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 11.25M shares, a 150.67% increase from fiscal 2023.
- CalciMedica, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 4.49M shares, a 5354.75% increase from fiscal 2022.
- CalciMedica, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 82.25K shares, a 99.61% decline from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 17.10M shares 10-Q · filed 2026-08-11 | 16.46M shares 10-Q · filed 2026-08-11 | 16.25M shares derived: average of 3 quarters · filed 2026-08-11 | 15.96M shares derived: average of 4 quarters · filed 2026-08-11 | ||||
| 2026-03-31 | 15.82M shares 10-Q · filed 2026-05-12 | 15.83M shares derived: average of 2 quarters · filed 2026-05-12 | 15.58M shares derived: average of 3 quarters · filed 2026-05-12 | 15.43M shares derived: average of 4 quarters · filed 2026-08-11 | ||||
| 2025-12-31 | 15.84M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | 15.46M shares derived: average of 2 quarters · filed 2026-03-03 | 15.30M shares derived: average of 3 quarters · filed 2026-08-11 | 15.01M shares 10-K · filed 2026-03-03 | ||||
| 2025-09-30 | 15.08M shares 10-Q · filed 2025-11-12 | 15.04M shares derived: average of 2 quarters · filed 2026-08-11 | 14.73M shares 10-Q · filed 2025-11-12 | 14.29M shares derived: average of 4 quarters · filed 2026-08-11 | ||||
| 2025-06-30 | 15.00M shares 10-Q · filed 2026-08-11 | 14.56M shares 10-Q · filed 2026-08-11 | 14.03M shares derived: average of 3 quarters · filed 2026-08-11 | 13.30M shares derived: average of 4 quarters · filed 2026-08-11 | ||||
| 2025-03-31 | 14.12M shares 10-Q · filed 2026-05-12 | 13.54M shares derived: average of 2 quarters · filed 2026-05-12 | 12.74M shares derived: average of 3 quarters · filed 2026-05-12 | 12.34M shares derived: average of 4 quarters · filed 2026-05-12 | ||||
| 2024-12-31 | 12.96M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | 12.05M shares derived: average of 2 quarters · filed 2026-03-03 | 11.74M shares derived: average of 3 quarters · filed 2026-03-03 | 11.25M shares 10-K · filed 2026-03-03 | ||||
| 2024-09-30 | 11.13M shares 10-Q · filed 2025-11-12 | 11.13M shares derived: average of 2 quarters · filed 2025-11-12 | 10.67M shares 10-Q · filed 2025-11-12 | 9.44M shares derived: average of 4 quarters · filed 2025-11-12 | ||||
| 2024-06-30 | 11.13M shares 10-Q · filed 2025-08-12 | 10.44M shares 10-Q · filed 2025-08-12 | 8.87M shares derived: average of 3 quarters · filed 2025-08-12 | 8.07M shares derived: average of 4 quarters · filed 2025-08-12 | ||||
| 2024-03-31 | 9.75M shares 10-Q · filed 2025-05-14 | 7.75M shares derived: average of 2 quarters · filed 2025-05-14 | 7.05M shares derived: average of 3 quarters · filed 2025-05-14 | 6.71M shares derived: average of 4 quarters · filed 2025-05-14 | ||||
| 2023-12-31 | 5.74M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | 5.70M shares derived: average of 2 quarters · filed 2025-03-27 | 5.69M shares derived: average of 3 quarters · filed 2025-03-27 | 4.49M shares 10-K · filed 2025-03-27 | ||||
| 2023-09-30 | 5.67M shares 10-Q · filed 2024-11-13 | 5.66M shares derived: average of 2 quarters · filed 2024-11-13 | 4.07M shares 10-Q · filed 2024-11-13 | 3.06M shares derived: average of 4 quarters · filed 2024-11-13 | ||||
| 2023-06-30 | 5.66M shares 10-Q · filed 2024-08-12 | 3.26M shares 10-Q · filed 2024-08-12 | 2.19M shares derived: average of 3 quarters · filed 2024-08-12 | 1.66M shares derived: average of 4 quarters · filed 2024-08-12 | ||||
| 2023-03-31 | 823.07K shares 10-Q · filed 2024-05-13 | 453.62K shares derived: average of 2 quarters · filed 2024-05-13 | 330.13K shares derived: average of 3 quarters · filed 2024-05-13 | 268.33K shares derived: average of 4 quarters · filed 2024-05-13 | ||||
| 2022-12-31 | 84.18K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | 83.67K shares derived: average of 2 quarters · filed 2024-03-28 | 83.42K shares derived: average of 3 quarters · filed 2024-03-28 | 82.25K shares 10-K · filed 2024-03-28 | 21.49M shares 10-K · filed 2023-03-09 | |||
| 2022-09-30 | 83.15K shares 10-Q · filed 2023-11-09 | 21.54M shares 10-Q · filed 2022-11-10 | 83.04K shares derived: average of 2 quarters · filed 2023-11-09 | 81.60K shares 10-Q · filed 2023-11-09 | 21.44M shares 10-Q · filed 2022-11-10 | 5.40M shares derived: average of 4 quarters · filed 2023-11-09 | ||
| 2022-06-30 | 82.92K shares 10-Q · filed 2023-08-11 | 21.43M shares 10-Q · filed 2022-08-12 | 80.81K shares 10-Q · filed 2023-08-11 | 21.40M shares 10-Q · filed 2022-08-12 | 7.17M shares derived: average of 3 quarters · filed 2023-08-11 | 10.70M shares derived: average of 4 quarters · filed 2023-08-11 | ||
| 2022-03-31 | 78.68K shares 10-Q · filed 2023-05-12 | 10.71M shares derived: average of 2 quarters · filed 2023-05-12 | 14.23M shares derived: average of 3 quarters · filed 2023-05-12 | 15.96M shares derived: average of 4 quarters · filed 2023-05-12 | ||||
| 2021-12-31 | 21.34M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | 21.31M shares derived: average of 2 quarters · filed 2023-03-09 | 21.26M shares derived: average of 3 quarters · filed 2023-03-09 | 21.20M shares 10-K · filed 2023-03-09 | ||||
| 2021-09-30 | 21.29M shares 10-Q · filed 2022-11-10 | 21.22M shares derived: average of 2 quarters · filed 2022-11-10 | 21.15M shares 10-Q · filed 2022-11-10 | |||||
| 2021-06-30 | 21.15M shares 10-Q · filed 2022-08-12 | 21.08M shares 10-Q · filed 2022-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |